Deva Holding AS | DEVA - Modal Dan Cadangan

Keuangan

TRY

TRY 12.93B

TRY 775.92M

Biaya Penjualan

TRY 991.13M

TRY 9.13B

Kewajiban Lancar

TRY 6.43B

TRY 5.3B

Dividen - Hasil

0.18

TRY 820.88M

TRY 882.9M

Eps Laba Per Saham

TRY 2.92

Modal Dan Cadangan

TRY 5.79B

Laba Kotor Pada Penjualan

TRY 1.32B

Beban Bunga Utang

TRY 272.53M

TRY 559.97M

Kapitalisasi Pasar

TRY 13.13B

Batas Pemasukan

TRY 583.98M

Biaya Operasional

TRY 1.35B

Laba Operasional

TRY 964.87M

Modal Saham Biasa

TRY 200.02M

Pe Harga Untuk Laba

6.55

Pendapatan Penjualan

TRY 2.32B

Beban Penjualan Dan Administrasi

TRY 462.26M

Kreditur Perdagangan

TRY 809.81M

Debitur Perdagangan

TRY 3.03B

	Modal Dan Cadangan	Perubahan		Tanggal
Akebia Therapeutics	USD 27.38M		5.24M	2026-03
Alaunos Therapeutics	USD 1.29M		865K	2026-03
Avita Medical	AUD -16.65M		3.76M	2025-12
Deva Holding AS	TRY 5.79B		604.07M	2023-09
Dianthus Therapeutics	USD 1.2B		707.91M	2026-03
Ionis Pharmaceuticals	USD 491.41M		2.32M	2026-03
IQVIA Holdings	USD 6.22B		282M	2026-03
Moderna	USD 7.41B		1.24B	2026-03
Organon & Co	USD 903M		151M	2026-03
Revvity	USD 7.25B		125.54M	2025-12
Tectonic Therapeutic	USD 230.42M		20.91M	2026-03
Viatris	USD 14.66B		53.6M	2026-03
Xeris Pharmaceuticals	USD 13.01M		678K	2026-03